NCT01135342

Brief Summary

The goal is to determine if improved sleep will increase/enhance weight loss among overweight adults with insomnia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 2, 2010

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

8 months

First QC Date

June 1, 2010

Last Update Submit

February 18, 2023

Conditions

Keywords

InsomniaWeight lossAdults

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in weight at 8 months

    Change was calculated as the value at 8 months minus the value at baseline.

    Baseline and 8 months

Secondary Outcomes (4)

  • Change from baseline in scores of Insomnia Severity Index

    Baseline and 8 months

  • Change from baseline in scores of Insomnia Frequency Questionnaire

    Baseline and 8 months

  • Change from baseline in scores of Pittsburgh Sleep Quality Index

    Baseline and 8 months

  • Change from baseline in scores of Monk Social Rhythm Questionnaire

    Baseline and 8 months

Study Arms (2)

Diet & Exercise plus Sleep Intervention

EXPERIMENTAL

Diet and exercise instruction to promote weight loss plus cognitive behavioral therapy for insomnia.

Behavioral: Diet and exerciseBehavioral: Cognitive Behavioral Therapy

Diet & Exercise plus Passion and Balance

SHAM COMPARATOR

Diet and exercise instruction to promote weight loss plus sessions that are of general interest, but unrelated to diet, exercise, or sleep.

Behavioral: Diet and exerciseBehavioral: Passion and Balance

Interventions

Standardized instruction to eat less and exercise more to create an energy balance deficit to promote weight loss (16 classes)

Diet & Exercise plus Passion and BalanceDiet & Exercise plus Sleep Intervention

Standardized cognitive behavioral therapy for insomnia (8 classes)

Diet & Exercise plus Sleep Intervention

Attention-match sessions of general interest, but unrelated to diet, exercise, or sleep (8 sessions)

Diet & Exercise plus Passion and Balance

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gender: Both women and men
  • Age: \> or = 18 years
  • Ethnicity and race: All ethnic and racial backgrounds welcome
  • The following, which will be measured at the screening clinic visit:
  • Body Mass Index: 28-40 (kg/m-squared)
  • Chronic Short Sleep: total sleep time \< 6.5 hours, greater than or equal to 4 days per week (determined by 1-week sleep log) for the past 6 months or longer (based on self-report).
  • Insomnia: sleep latency and/or wake after sleep onset \> 30 minutes, greater than or equal to 4 days per week, insomnia severity index \> 10, and complaint of at least one negative effect during waking hours (such as fatigue, sleepiness, impaired functioning, mood disturbance) attributed to sleep (as determined by self report).
  • Eligible sleep disorder: sleep apnea or upper airway resistance syndrome treated by positive airway therapy for \> or = 3 months resulting in improved sleep.
  • Psychiatric disorders that are stable on SSRI, SNRI, or bupropion antidepressant for greater than or equal to 3 months if no anticipated changes in medications to occur during the trial if they are weight stable.
  • Planning to be available for clinic visits and for the 8 weeks of study participation
  • Ability and willingness to give written informed consent.

You may not qualify if:

  • Sleep apnea (apnea-hypopnea index \> 15/hr) determined by portable sleep diagnostic system Periodic limb movements during sleep (PLM with arousal index \> 15/hr) determined by polysomnography.
  • Any suspected sleep disorders identified by the Global Sleep Assessment Questionnaire, including circadian rhythm disorders (including shift work), parasomnias, narcolepsy, and restless leg.
  • Self reported personal history of:
  • Subjects currently receiving the following medications known to affect sleep(self report):
  • sedative hypnotics
  • sedative antidepressants
  • systemic steroids
  • anticonvulsants
  • histamine-1
  • receptor antagonists
  • narcotic analgesics
  • CNS stimulants
  • Body Mass Index (BMI) greater than 40.
  • Pregnant, Lactating, or \<6 months post-partum.
  • Inability to communicate effectively with study personnel.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Related Links

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersObesityWeight Loss

Interventions

DietExerciseCognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Christopher D Gardner

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine (Research)

Study Record Dates

First Submitted

June 1, 2010

First Posted

June 2, 2010

Study Start

July 1, 2009

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

February 22, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations